NeuralStockNeuralStock
PortfolioPortfolio mode

BMY

Bristol Myers Squibbstock
$61.482.41% today

Research BMY

BMY · 90-day price history

Market cap

$126.0B

P/E

13.6

Div yield

4.09%

Industry

Drug Manufacturers - General

Exchange

NYSE

Website ↗

Prediction models

All predictions →

Trend follower

Horizon: 1 week

down
Signal strength0.73
Historical accuracy33%
27 predictions · 12mBaseline 50%
How this works

Compares a 10-day vs 50-day moving average. When the short-term average rises above the long-term average, the trend is up.

Not financial advice. Past accuracy does not guarantee future results.

Momentum

Horizon: 1 week

up
Signal strength0.26
Historical accuracy37%
27 predictions · 12mBaseline 50%
How this works

Uses RSI (a gauge of recent buying/selling intensity) and 5-day rate-of-change to judge whether the stock has been pushed too far in one direction.

Not financial advice. Past accuracy does not guarantee future results.

Statistical trend

Horizon: 1 month

down
Signal strength0.70
Historical accuracy10%
10 predictions · 12mBaseline 52%
How this works

Fits a trend line through the last 60 days of prices and measures how far the current price has strayed from it.

Not financial advice. Past accuracy does not guarantee future results.

Multi-factor + news

Horizon: 1 week

AI + NEWS
down
Signal strength0.10
Historical accuracy30%
27 predictions · 12mBaseline 50%

Accuracy reflects technical signals only. News sentiment is live.

How this works

Combines trend (25%), momentum (25%), volume (15%), and AI-analysed news sentiment (35%) from your trusted sources into one score.

Not financial advice. Past accuracy does not guarantee future results.

Bull / Bear thesis

AI analysis
Bull case●

New Phase 3 clinical readouts in cancer and pulmonary fibrosis

Pipeline showing advancement with multiple data presentations planned

Yahoo

Cancer Collective Action Collaborative shows strategic partnerships expanding access

IHI partnership improving clinical trial access

Yahoo

Stock back in investor spotlight with multiple clinical catalysts

Multiple near-term clinical data presentations upcoming

Yahoo
Bear case●

Q3 earnings expected to decline year-over-year

Revenue pressure evident despite pipeline activity

Yahoo

Stock down 0.91% despite clinical progress

Market skeptical clinical data will drive earnings growth

Price action

Clinical data is forward-looking; current earnings deterioration is negative

Near-term financial weakness outweighs future pipeline potential

Price action

AI-generated from recent news and price action. Not financial advice. Educational only.

Seasonality

~5y of history

Avg return by month · %

JFMAMJJASOND

This month historically: +0.39% on average, up 60% of 5 years.

Avg return by weekday · %

MonTueWedThuFri

Historical pattern only — seasonality is not a prediction and often breaks.

Recent news

Bristol Myers launching cancer clinical collaborative with IHI

Yahoo · Oct 22

Partnership improves patient access to clinical trials for new cancer treatments

Bristol Myers presenting new oncology data at ESMO congress

Yahoo · Oct 22

Major oncology conference presentation signals confidence in pipeline data

AI research companion

AI Research Companion

Loading…